Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.7K
Overview
44.7K
Symbiosis00:58

Symbiosis

28.6K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
28.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A trial-blazer in clinical research.

Immunology and cell biology·2025
Same author

Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart disease.

mBio·2025
Same author

Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections.

Nature communications·2024
Same author

When academia met industry: working toward a needle-free vaccination future in the sunshine state.

Immunology and cell biology·2024
Same author

A CAF01-adjuvanted whole asexual blood-stage liposomal malaria vaccine induces a CD4<sup>+</sup> T-cell-dependent strain-transcending protective immunity in rodent models.

mBio·2023
Same author

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils.

Nature communications·2023
Same journal

Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Gene Therapy Strategies for Uveal Melanoma: Adeno-associated Virus Delivery Challenges and Translational Opportunities.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Review of Quality Attributes and Analytical Methods Used for Comparative Analytical Assessment of Monoclonal Antibodies as Part of Successful Biosimilar Approvals in the United States and European Union.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

An Overview and Trend Analysis of Biosimilar Approvals in China.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
See all related articles

Related Experiment Video

Updated: Jul 16, 2025

Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

1.4K

Malaria Vaccines: Progress to Date.

Danielle I Stanisic1, Michael F Good2

  • 1Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, QLD, Australia. d.stanisic@griffith.edu.au.

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|September 20, 2023
PubMed
Summary
This summary is machine-generated.

Developing effective malaria vaccines is crucial for disease eradication. While RTS,S/AS01 is recommended for children, new candidates like R21 show promising high-level efficacy against Plasmodium falciparum.

More Related Videos

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.0K
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.1K

Related Experiment Videos

Last Updated: Jul 16, 2025

Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

1.4K
Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.0K
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.1K

Area of Science:

  • Immunology
  • Tropical Medicine
  • Vaccinology

Background:

  • Malaria, a mosquito-borne parasitic disease, remains a significant global health challenge despite progress.
  • The development of highly effective malaria vaccines is essential for disease control and eradication efforts.
  • Current strategies necessitate improved prevention and treatment options to combat Plasmodium falciparum.

Purpose of the Study:

  • To review malaria vaccine candidates that have advanced into clinical trials.
  • To highlight the most promising and advanced malaria vaccine candidates currently in development.
  • To assess the potential of novel vaccine strategies in achieving long-lasting protective immunity against malaria.

Main Methods:

  • Review of clinical trial data for malaria vaccine candidates.
  • Analysis of efficacy and safety profiles of leading vaccine candidates.
  • Discussion of ongoing research and development in malaria vaccinology.

Main Results:

  • RTS,S/AS01 (Mosquirix) is the most advanced malaria vaccine, recommended for children in Africa.
  • RTS,S/AS01 demonstrated modest efficacy against clinical malaria in phase III trials.
  • Newer candidates, including Sanaria's PfSPZ Vaccine, PfSPZ-CVac, and R21, are showing promising results in clinical evaluations.
  • The R21 malaria vaccine candidate exhibited high-level efficacy in a recent phase IIb trial.

Conclusions:

  • More effective malaria vaccines are urgently needed to supplement existing control measures.
  • Advanced vaccine candidates like R21 offer potential for improved protection against Plasmodium falciparum.
  • Continued research and development are vital for achieving malaria eradication through vaccination.